新型敷料Kerraboot治疗糖尿病足溃疡的疗效观察

Effect of A New Wound Management System Kerraboot~ for Diabetic Foot Ulcer

目的观察新型敷料Kerraboot治疗糖尿病足溃疡的临床疗效。方法 本研究入选糖尿病足溃疡患者3例,连续使用Kerraboot4周。记录患者的病史,数码拍照记录每周创面愈合情况。观察结束后随访患者至糖尿病足创面愈合。结果 3例患者创面分级为Wagner 1～2级。使用Kerraboot期间创面愈合加快,平均愈合速度为4.39～40.34 mm2/d。不良反应轻微。结论 Kerraboot适用于治疗糖尿病足溃疡,能明显促进糖尿病足溃疡的创面愈合。

Objective To investigate the clinical efficacy of a new wound management system,Kerraboot,designed for the management of leg and foot ulcers. Methods This was a small sample prospective trial of four weeks that three patients with diabetic foot ulcer were included.Clinical efficacy was accessed in terms of mean changes in ulcer size.Patients were followed till ulcers completely healed. Results The classification of diabetic foot ulcers of the three patients were Wagner 1～2.Kerraboot significantly increased wound healing rate which mean changes in ulcer size were 4.39～40.34 mm2/d.Adverse incidents were slight. Conclusion Kerraboot is recommended for the management of diabetic foot ulcers.